Gender differences in hypertension awareness, diagnosis and treatment
DOI:
https://doi.org/10.12775/JEHS.2023.13.03.007Keywords
Public health, sex difference, hypertension, cardiovascular diseaseAbstract
Introduction: Hypertension is most important risk factor for cardiovascular disease (CD) and stroke, two of the leading causes of death in adults worldwide. Even though over last decade there has been improvement in increasing the awareness, treatment, and control of hypertension, undiagnosed and uncontrolled hypertension remain one of main public health challenges. In order to make progress in dealing with this problem it important to understand in which areas of the treatment strategy appropriate changes have not yet been implemented. First step to do this is to improve our understanding of the factors that affect the treatment and control of hypertension. International Guidelines for hypertension recommend the same hypertension management for both sexes, however studies reveal that there are actual differences in hypertension management.
Purpose of the study: The aim of this study was to conduct a paper review to provide most comprehensive contemporary estimates of sex differences in the awareness, treatment, and control of hypertension.
Material and method: A literature review was conducted in English language databases, based only on original articles, regarding awareness, control and treatment of hypertension, using key words: ‘hypertension’, ‘sex- differences’, ‘hypertension treatment’, ‘gender gap’, ‘public health’.
Results and conclusions: Based on researched studies we can state that woman have higher awareness, treatment and control rates for hypertension than men worldwide [4,5,6,7,8,9,10]. This suggests that, the guidelines for the treatment and management of hypertension should be gender specific.
References
World Health Organization. Hypertension. https://www.who.int/news-room/fact-sheets/detail/hypertension (access: 12.19.2022).
Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016 Mar 5;387(10022):957-967. doi: 10.1016/S0140-6736(15)01225-8.
Park YH, Kim H, Jang SN, Koh CK. Predictors of adherence to medication in older Korean patients with hypertension. Eur J Cardiovasc Nurs. 2013 Feb;12(1):17-24. doi: 10.1016/j.ejcnurse.2011.05.006.
Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010 May 26;303(20):2043-50. doi: 10.1001/jama.2010.650.
Redfern A, Peters SAE, Luo R, Cheng Y, Li C, Wang J, Anderson C, Wang H, Norton R. Sex differences in the awareness, treatment, and control of hypertension in China: a systematic review with meta-analyses. Hypertens Res. 2019 Feb;42(2):273-283. doi: 10.1038/s41440-018-0154-x
Rahman M, Williams G, Al Mamun A. Gender differences in hypertension awareness, antihypertensive use and blood pressure control in Bangladeshi adults: findings from a national cross-sectional survey. J Health Popul Nutr. 2017 May 25;36(1):23. doi: 10.1186/s41043-017-0101-5.
Kim JS, Kim CG. Gender Differences in Hypertension Treatment and Control in Young Adults. J Nurs Res. 2020 Jun;28(3):e88. doi: 10.1097/JNR.0000000000000359.
Sarganas G, Neuhauser HK. The persisting gender gap in hypertension management and control in Germany: 1998 and 2008-2011. Hypertension research : official journal of the Japanese Society of Hypertension 2016; 39(6): 457-66.
Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997; 10 (10 Pt 1): 1097–1102.
Cífková R, Bruthans J, Strilchuk L, Wohlfahrt P, Krajčoviechová A, Šulc P, Jozífová M, Eremiášová L, Pudil J, Linhart A, Widimský J Jr, Filipovský J, Mayer O Jr, Škodová Z, Lánská V. Longitudinal trends in blood pressure, prevalence, awareness, treatment, and control of hypertension in the Czech population. Are there any sex differences? Front Cardiovasc Med. 2022 Nov 10;9:1033606. doi: 10.3389/fcvm.2022.1033606.
Muiesan ML, Salvetti M, Rosei CA, Paini A. Gender Differences in Antihypertensive Treatment: Myths or Legends? High Blood Press Cardiovasc Prev. 2016 Jun;23(2):105-13. doi: 10.1007/s40292-016-0148-1.
Kalibala J, Pechère-Bertschi A, Desmeules J. Gender Differences in Cardiovascular Pharmacotherapy-the Example of Hypertension: A Mini Review. Front Pharmacol. 2020 May 6;11:564. doi: 10.3389/fphar.2020.00564.
Pechère-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens. 2004 Oct;17(10):994-1001. doi: 10.1016/j.amjhyper.2004.08.009.
Cadeddu C, Franconi F, Cassisa L, Campesi I, Pepe A, Cugusi L, Maffei S, Gallina S, Sciomer S, Mercuro G; Working Group of Gender Medicine of Italian Society of Cardiology. Arterial hypertension in the female world: pathophysiology and therapy. J Cardiovasc Med (Hagerstown). 2016 Apr;17(4):229-36. doi: 10.2459/JCM.0000000000000315.
Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J, Perkovic V, Li N, MacMahon S; Blood Pressure Lowering Treatment Trialists' Collaboration. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008 Nov;29(21):2669-80. doi: 10.1093/eurheartj/ehn427.
Zapater P, Novalbos J, Gallego-Sandín S, Hernández FT, Abad-Santos F. Gender differences in angiotensin-converting enzyme (ACE) activity and inhibition by enalaprilat in healthy volunteers. J Cardiovasc Pharmacol. 2004 May;43(5):737-44. doi: 10.1097/00005344-200405000-00018.
Thoenes M, Neuberger HR, Volpe M, Khan BV, Kirch W, Böhm M. Antihypertensive drug therapy and blood pressure control in men and women: an international perspective. J Hum Hypertens. 2010 May;24(5):336-44. doi: 10.1038/jhh.2009.76.
Hwang KS, Kim GH. Thiazide-induced hyponatremia. Electrolyte Blood Press. 2010 Jun;8(1):51-7. doi: 10.5049/EBP.2010.8.1.51.
Rodenburg EM, Stricker BH, Visser LE. Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands. Br J Clin Pharmacol. 2011 Jan;71(1):95-104. doi: 10.1111/j.1365-2125.2010.03811.x.
Rydberg DM, Mejyr S, Loikas D, Schenck-Gustafsson K, von Euler M, Malmström RE. Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs. Eur J Clin Pharmacol. 2018 Sep;74(9):1165-1173. doi: 10.1007/s00228-018-2480-y.
Thürmann PA, Haack S, Werner U, Szymanski J, Haase G, Drewelow B, Reimann IR, Hippius M, Siegmund W, May K, Hasford J. Tolerability of beta-blockers metabolized via cytochrome P450 2D6 is sex-dependent. Clin Pharmacol Ther. 2006 Nov;80(5):551-3. doi: 10.1016/j.clpt.2006.08.004.
Daugherty SL, Masoudi FA, Ellis JL, Ho PM, Schmittdiel JA, Tavel HM, Selby JV, O'Connor PJ, Margolis KL, Magid DJ. Age-dependent gender differences in hypertension management. J Hypertens. 2011 May;29(5):1005-11. doi: 10.1097/HJH.0b013e3283449512
Biffi A, Rea F, Iannaccone T, Filippelli A, Mancia G, Corrao G. Sex differences in the adherence of antihypertensive drugs: a systematic review with meta-analyses. BMJ Open. 2020 Jul 8;10(7):e036418. doi: 10.1136/bmjopen-2019-036418
Lunet N, Barros H. Gender differences in the treatment of hypertension: a community based study in Porto. Rev Port Cardiol. 2002 Jan;21(1):7-19. English, Portuguese. PMID: 11941903.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Martyna Janczewska, Alicja Bielak, Agata Kolasa, Zuzanna Radziejowska, Magdalena Szklarz
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 124
Number of citations: 0
